Compared with colleagues in other medical specialties, dermatologists have enjoyed a relatively low risk of being sued for medical malpractice. However, when litigation comes to fruition and is successful, the judgment award to the plaintiff is typically much higher for dermatology cases compared with the national average, says Whitney A. High, M.D., J.D., M.Eng. What's more, dermatopathologists rank second-highest among medical specialists for the number of $1 million-plus verdicts.
Modern Medicine Now
Once-daily application of Sansrosa (brimonidine tartrate/BT gel, Galderma) 0.5 percent has proven safe and effective for treating the persistent facial erythema of rosacea, according to the results of a phase 2 trial.
The first long-term trial of Latisse (bimatoprost ophthalmic solution 0.03 percent, Allergan) shows that daily application of the eyelash enhancer for up to one year is safe and effective for patients with idiopathic and chemotherapy-induced hypotrichosis.
A dermatology practice is a hotbed of activity. In addition to the clinical care you provide, there is staff to manage in carrying out your orders, supplies to use, bills to be sent and money to be tracked. The complexity of a practice makes outsourcing — using outside firms to handle work you would normally perform in-house — appear quite appealing.
A topical combination of vitamin C, vitamin E and ferulic acid (CE Ferulic, SkinCeuticals) appears to provide protection against skin damage induced by infrared A (IR-A) radiation, said Jean T. Krutmann, M.D., professor of dermatology and environmental medicine and director at the IUF – Leibniz Research Institute for Environmental Medicine, D?sseldorf, Germany, at the 70th annual meeting of the American Academy of Dermatology.
Barbara Mathes, M.D., started her healthcare career as an emergency room nurse. She remembers answering medical residents' questions, and the residents would tell her she might as well go into medicine. Her reply? "One day I think I will." So started a multifaceted professional life in dermatology, which has included private practice, teaching, industry work, research and more.
The latest melanoma staging system from the American Joint Committee on Cancer (AJCC) and a tool developed for predicting the clinical outcome of individual patients with localized or regional cutaneous melanoma (www.melanomaprognosis.org) have stirred debate among dermatopathologists.
Dermatology has a committed ambassador in Capitol Hill, but it's tragic as to why. Rep. Brian Bilbray (R-Calif.) and his youngest daughter, Briana, both have been diagnosed with skin cancer and are speaking out about it to encourage others to prevent and detect skin cancer early. The congressman has co-sponsored the Melanoma Research Act of 2012, which would provide funding for skin cancer research.
While the incidence of melanoma is lower among African-Americans than it is among Caucasians, mortality due to melanoma is higher among the former. The reason, experts say, is because skin cancers in African-Americans appear on sites where they behave more aggressively, and there is a delay in diagnosis with this patient population.
Patients with skin of color cope with a number of skin concerns, but treatment advances are helping dermatologists treat these patients effectively. Pigmentation changes are a major concern for these patients, experts say.